Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.60
+0.14 (1.65%)
At close: Nov 20, 2024, 4:00 PM
8.36
-0.24 (-2.79%)
Pre-market: Nov 21, 2024, 6:07 AM EST
Grifols Employees
Grifols had 23,737 employees as of December 31, 2023. The number of employees decreased by 2,577 or -9.79% compared to the previous year.
Employees
23,737
Change (1Y)
-2,577
Growth (1Y)
-9.79%
Revenue / Employee
$329,195
Profits / Employee
$7,588
Market Cap
6.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
Dec 31, 2021 | 23,234 | -421 | -1.78% |
Dec 31, 2020 | 23,655 | -348 | -1.45% |
Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
Dec 31, 2016 | 14,877 | 140 | 0.95% |
Dec 31, 2015 | 14,737 | 757 | 5.41% |
Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
Dec 31, 2013 | 11,779 | 671 | 6.04% |
Dec 31, 2012 | 11,108 | -122 | -1.09% |
Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
Dec 31, 2010 | 5,968 | -16 | -0.27% |
Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
The Ensign Group | 35,300 |
Chemed | 15,087 |
Bausch + Lomb | 13,300 |
Bruker | 9,707 |
Jazz Pharmaceuticals | 2,800 |
Legend Biotech | 1,826 |
Repligen | 1,783 |
GRFS News
- 2 days ago - Grifols: Brookfields potential $6.8 bln offer undervalues the firm - Reuters
- 2 days ago - Spanish court opens investigation into Gotham City's attack on Grifols - Reuters
- 2 days ago - Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors - Business Wire
- 3 days ago - Brookfield mulls $7.4 bln bid for Spain's Grifols, El Confidencial says - Reuters
- 12 days ago - Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors - Business Wire
- 13 days ago - Grifols on track to meet 2024 targets despite third-quarter profit drop - Reuters
- 6 weeks ago - Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down - Seeking Alpha
- 7 weeks ago - Grifols plans to invest $402 million in new industrial centre, El Economista says - Reuters